A position statement of the society of cardiac angiography and interventions
| T RA N S LE S I O NA L P HY S I O LO G IC M E A SU RE M EN TS
Adding physiologic assessment to the angiographic appraisal of severity enhances the accuracy of diagnosis and optimizes the selection of patients for revascularization and other treatment options [3] . Current practice is to continue to rely on angiography when there is unmistakably a severe, or conversely an insignificant, stenosis, particularly when there is correlation with ischemia by stress testing. Fractional flow reserve (FFR) and resting pressure assessment correlate with prognosis and stress test results [4] . Intracoronary physiological assessment becomes decisive when there is conflicting information among symptoms, ischemic testing, and angiographic anatomy [5] . 
| N ON-H YP E RE M IC P RE SSU R E-D ER I VE D I ND I CE S

| Resting pressure ratio: Instantaneous wave-free ratio
Instantaneous wave-free ratio (iFR) is the P d /P a measured during a select portion of diastole, the wave-free period (WFP), when the forces which influence coronary flow are quiescent; hence, microvascular resistance is theoretically constant and minimal. Consequently, pressure and flow are linearly related over the WFP [6] . iFR is calculated by measuring the resting translesional pressure ratio (P d /P a ) during the WFP [7] . iFR assesses the functionality of the coronary stenosis without the necessity of maximal hyperemia [7] [8] [9] [10] , removing the possibility of pharmacologicinduced complications and concern whether maximal vasodilation has been produced. iFR values >0.89 likely exclude ischemia.
| Whole cycle resting distal to proximal pressure ratio: (P d /P a )
advantageous. iFR is non-inferior to FFR with respect to predicting clinical outcomes [21, 22] . Thus, FFR or iFR is the best single measure of PCI propriety when there is any uncertainty as to significance of a stenosis. These tests predict a worse outcome if abnormal and the stenosis not revascularized, and a good outcome if treated medically when above the ischemic threshold [23, 24] . In the iFR-SWEDEHEART trial [21] , 2,037 patients were randomized to iFR or FFR-guided PCI for lesions with 40%-80% angiographic stenosis. Revascularization was advised if iFR 0.89 or FFR 0.80.
MACE was similar in the two groups (6.7% in the iFR group and 6.1% in the FFR group, 95% confidence interval [CI], 21.5 to 2.8; P 5 0.007 for non-inferiority).
In DEFINE-FLAIR [22] , 2,492 patients were randomized to iFR or FFR-guided PCI for stenoses of 40%-70% by angiography. Revascularization was advised if iFR 0.89 or FFR 0.80. MACE was similar in the two groups at 12 months post-PCI (6.8% in the iFR group and 7.0% in the FFR group, hazard ratio 5 0.95, 95% CI, 0.68 to 1.33; P < 0.001 for non-inferiority).
It should be observed that FFR/iFR validation studies were performed in patients without severe hypertrophy, prior MI, CHF, pulmonary hypertension, or valvular heart disease. Increased LVEDP after MI increases microvascular resistance, falsely increasing FFR [25] ; iFR in this setting has not been studied.
| Multivessel CAD and coronary artery bypass grafting versus PCI
In multivessel CAD, these techniques have been advocated for improved selection of patients for coronary artery bypass grafting (CABG) versus PCI [3, 5] . By discounting intermediate but non-ischemic lesions, the functional SYNTAX score can be calculated and angiographic 3-vessel CAD might be reclassified as 1-or 2-vessel CAD, which could benefit from PCI and not require CABG [26] . Whether or not FFR can be used to optimally select patients for CABG is uncertain [27] , and is under study (FAME III). Validated cut-off values may not predict graft longevity or MI prevention; the long-term effect of not grafting angiographically borderline but functionally insignificant stenoses is unknown.
In one small study [28] , the 1-year patency rate was higher in both vein graft and arterial conduits when FFR-guided. In patients with intermediate lesions undergoing CABG, FFR decreased the number of CABG procedures and number of grafts, but there was no difference in MACE at 3 years [29] . There are ongoing randomized outcome trials evaluating the utility of FFR on surgical revascularization (Table 3) . 
| Left main coronary stenosis (LMCA)
LMCA stenoses are accurately evaluated with FFR when there are no significant stenoses located downstream (Table 4 ). An FFR- Abbreviations: iFR, instantaneous wave-free ratio; FFR, fractional flow reserve; PCI, percutaneous coronary intervention; MI, myocardial infarction; Revas, revascularization; non-STEMI, non-ST-segment elevation myocardial infarction; ACS, acute coronary syndrome; CABG, coronary artery bypass surgery. *Primary end point: death, non-fatal myocardial infarction, unplanned revascularization.
guided revascularization strategy can be safely applied to patients with LMCA stenosis [34, 38] . Catheter damping should be meticulously avoided. It should be recognized that IFR has never been evaluated in this setting.
| Acute coronary syndromes
These techniques have no role in assessing culprit lesions within 72 hr of presentation. In the acutely injured myocardial bed, transient impairment may result in an initially false negative (normal) FFR. As the viable myocardium in the affected region recovers, hyperemic flow may increase, and consequently the FFR of the culprit lesion may decrease.
In NSTEMI, FFR in non-culprit lesions may safely guide complete revascularization (Table 5) . iFR SwedeHeart and DEFINE-FLAIR included 20%-30% of patients with acute coronary syndromes. 56% of non-culprit angiographically significant non-culprit lesions had normal FFR, a large incidence of angiographic misclassification [43] likely related to increased sympathetic discharge, microvascular obstruction and increased coronary resistance [44] . Decreasing FFR at repeat measurement 1 month after STEMI with >20 mmHg enddiastolic pressure during the acute event has been demonstrated [45] .
| Aortic stenosis (AS) and TAVR
The accuracy of FFR and iFR is uncertain when assessing coronary stenosis severity in AS prior to TAVR. In severe AS, the conventional iFR cut-off has lower diagnostic agreement with FFR compared to stable CAD patients [36, 37] . These techniques have been evaluated in small series and the data are weak and inconsistent (Table 4) . Some intermediate stenoses with normal or borderline FFR values pre-TAVR may be underestimated. The incidence of misclassification is 6%-8% [36] . The Abbreviations: FFR, fractional flow reserve; Revas, revascularization; non-STEMI, non-ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; Angio, angiographically.
FIGURE 1 Relations between flow and pressure indices (iFR and FFR).
When FFR is positive and iFR negative, the flow is identical to that in unobstructed arteries. However, when FFR is negative and iFR is positive, flow is severely impaired. This explains the discordance between iFR and FFR and demonstrates that iFR is more closely related to flow than FFR [73] . Permission granted for reproduction [Color figure can be viewed at wileyonlinelibrary.com]
correlation between iFR and FFR is reasonable but the diagnostic accuracy of iFR was significantly lower in AS with CAD [46] (76.3% vs.
86.1%, P 5 0.009).
| Tandem and serial lesion assessment (Table 4)
Tandem lesions exist when there are two lesions of possible angiographic significance in the same coronary artery, separated by an angiographically normal segment [47] . The correct approach requires measuring the DP to determine the relative importance of each lesion's contribution to flow resistance [7, [48] [49] [50] . FFR is measured beyond the distal lesion (FFR summed ). If FFR summed is >0.80, deferring PCI should be considered. If FFR summed is <0.80, then pressure wire pullback during adenosine induced hyperemia proceeds. The lesion with the largest DP is treated, then FFR is performed for the remaining lesion; if FFR is <0.80, then stent, and conclude with a final FFR. Intravenous adenosine may be preferred over repeated intracoronary injections.
It is possible to predict the severity of individual stenosis with a single pullback using iFR [9] .
| Bypass grafts
FFR/iFR should be accurate in assessing bypass graft lesion severity when the inflow from the native artery is occluded. Residual native flow and collaterals provide additional sources of perfusion, but does not invalidate the FFR value if their contribution is minimal. However, the main question in SVG PCI is whether it alters the natural history of the conduit, which is beyond the FFR/iFR scope of function [51] .
| Correlation of FFR with iFR
Clinical studies correlating iFR with FFR demonstrate that the strength of the relationship depends on the distribution of the stenosis severity included [24, 52] . The classification match between iFR and FFR is 80% [52, 53] . In VERIFY 2 [54] the level of misclassification was in proximal versus non-proximal coronary lesions (27.7% vs. 15.2%, P 5 0.014).
Discordant results between FFR and iFR [13] are not associated with increased risk of events at 2 years. The highest rate of clinical events was in the FFR abnormal/iFR normal group. Outcomes studies [52] [53] [54] show non-inferiority of iFR when compared to FFR in low-risk patients.
This discrepancy could be related to the fact that iFR (Figure 1 ) may correlate with coronary flow reserve while FFR may be more specific for epicardial vessel flow (Figure 2 ).
FIG URE 2 FFR correlates with relative flow reserve significantly better than iFR or resting P d /P a . FFR, iFR, and resting P d /P a are compared with the non-invasive gold standard for detecting epicardial artery induced ischemia, PET-derived relative flow reserve. FFR correlates with relative flow reserve significantly better than iFR or resting P d /P a . Relative flow reserve is specific for the epicardial vessel and independent of the microvasculature, unlike CFR, which interrogates the entire coronary circulation. Adapted from [15] [Color figure can be viewed at wileyonlinelibrary.com] 
| Reproducibility and "gray zone" results
Both FFR and iFR measurements have been shown to be reproducible.
However, the reproducibility of classification between significant and not significant decreases as the value approaches the established cutpoint [52] [53] [54] . A 20% misclassification error led to the suggestion that clinicians make revascularization decisions based on broadened clinical judgment when FFR values fall in the 0.77 and 0.83 range [55] .
Whether routinely repeating the measure limits misclassification is unknown.
Non-hyperemic pressure-derived indices rely on smaller differences in transstenotic pressure than FFR and so are more vulnerable to technical and procedural errors (e.g., signal drift) [55, 56] .
| I NV A SI V E C ORON A RY I M A GI NG
Persuasive evidence regarding the clinical application of invasive coronary imaging [intravascular ultrasound (IVUS) and optical coherence tomography (OCT)] to assess lesion morphology exists. IVUS and OCT offer excellent visualization of intraluminal coronary structure, particularly at the mural surface and lumen interface. They may be especially useful in planning PCI strategy in high-risk subsets, such as left main stenosis, calcified lesions, and bifurcations [57, 58] . They also provide information regarding optimal stent expansion, identifying etiology of acute vessel closure, and provide insight into the mechanism for late stent failure.
Both techniques involve an intracoronary catheter to visualize vessel wall lumen morphology, endothelium, and microstructure [2] . IVUS uses ultrasound to create images. Recent advances include real-time three-dimensional reconstruction. OCT uses light to capture micrometer-resolution, three-dimensional images. The images are based on low-coherence interferometry, typically employing nearinfrared light.
| Stenosis severity assessment
IVUS is a mature technology whose benefits and limitations in assisting diagnostic evaluation of intermediate non-LMCA lesions are well 
Recommendations
FFR/iFR
Definitely beneficial:
In SIHD, when non-invasive stress imaging is uncertain, non-diagnostic or unavailable, FFR/iFR can be used to assess the functional significance of intermediate coronary stenoses.
In SIHD, PCI of lesions found significant by FFR/iFR improves symptom control and decreases the need for hospitalization requiring urgent revascularization when compared to medical therapy alone. Abnormal values should be considered in context of the patient's entire clinical picture.
In SIHD, medical therapy is indicated for an angiographically intermediate non-LMCA stenosis when FFR >0.80 or iFR >0.89.
In SIHD, medical therapy is indicated for an angiographically intermediate LMCA stenosis when FFR >0.80.
In SIHD, to assess the severity of stenoses in series and select targets for stenting
In multivessel coronary disease, PCI guided by FFR measurement improves outcomes and saves resources when compared to angiography guided PCI.
Probably beneficial
In multivessel coronary disease, measuring FFR/iFR may allow reclassification of number of vessels diseased (Functional SYNTAX score), and consequently guide decisions regarding revascularization by CABG or PCI.
In non-culprit lesions during STEMI, FFR may be valuable in determining which stenoses should be treated earlier and which can be deferred.
No proven value/should be discouraged:
During acute STEMI or unstable acute coronary syndrome, within 72 hr of presentation, in the culprit artery
There are no validation studies in the presence of left ventricular hypertrophy, CHF, pulmonary hypertension, or valvular heart disease.
IVUS Definitely beneficial:
IVUS is an accurate method to determine complete stent expansion and apposition and lack of edge dissection or other complications after implantation, and the size of the vessel undergoing stent implantation.
Probably beneficial:
IVUS can be used to appraise the significance of LMCA stenosis and, employing a cutoff MLA >6 mm 2 , to assess whether revascularization is warranted. It is recommended when downstream severe stenoses are present.
Possibly beneficial:
IVUS imaging may be used to characterize plaque morphology (i.e., calcification), which may alter the PCI technique chosen IVUS has been shown in meta-analyses to decrease major adverse events in PCI
In long lesion/long stents, IVUS guided PCI is associated with significantly reduced MACE
IVUS measurements for determination of non-LMCA lesion severity should not be performed to determine stenosis significance.
(Continues) Determination of optimal stent deployment (sizing, apposition, and lack of edge dissection), with improved resolution compared to IVUS.
OCT may be useful for assessment of plaque morphology.
During PCI, OCT can assess presence and extent of coronary dissection.
During PCI, OCT can assess hazy lesions of uncertain etiology or severity, or post-PCI suspected edge dissections
OCT should not be performed to determine stenosis significance LOTFI ET AL.
| 7
Summary of recommendations known [2] . In non-LMCA lesions, there is only moderate correlation between anatomic dimensions by IVUS and significance by physiological assessment. Thus, its use in decision-making is strongly discouraged.
In proximal stenoses when the cross-sectional area (CSA) <4 mm 2 and especially <3 mm 2 , the images may be useful if correlated with other diagnostic modalities [59] . The primary limitation of IVUS in predicting hemodynamic significance in non-LMCA lesions is that the functional effects of a lesion are dependent on additional factors besides dimension [60] .
In LMCA stenoses, IVUS assessment has a relatively strong correlation with FFR. A normal FFR can be predicted reasonably well with CSA >6.0 cm 2 [59, 61, 62] . Severe proximal LAD and/or LCX disease may impact FFR of LMCA stenoses, and in these cases, IVUS might be preferred. CSA between 4.8 and 6.0 cm 2 is probably abnormal [2] . Distal LMCA lesions may be difficult to accurately image with IVUS, and bifurcation lesions may require pullback from both the LCX and LAD to make an accurate assessment.
5 | A P P L IC AT I ONS I N P CI
| Left main coronary artery PCI
For LMCA stenosis, IVUS is an important procedural adjunct, both preand post-intervention evaluation [63] . At 3 years, MACE was significantly decreased in the IVUS-guided group (IVUS 88.7% vs. no-IVUS 83.6%, P 5 0.04) [64] .
| Non-left main coronary artery PCI
Two meta-analyses [43, 63] (Table 6 ) have concluded that IVUS-guided PCI has superior clinical outcomes to angiography-guided PCI. The strength of this finding rests on the reduction in ischemia-driven target lesion revascularization. There is also suggestive evidence that the risk of mortality and stent thrombosis might be lower with an IVUS-guided approach.
The ADAPT-DES study evaluated 1-year outcomes in patients undergoing PCI with DES [65] . There was a significant reduction in definite/probable stent thrombosis (0.52% vs. 1.04%, P 5 0.01) and MI (2.5% vs. 3.7%, P 5 0.002) but no reduction in mortality (1.0% vs. 1.4%, OCT can demonstrate thrombus, unrecognized plaque rupture, stent under-expansion, significant edge dissections, or excessive plaque at the stent edges treatable with further stent expansion or the placement of additional stents similar to IVUS but with improved resolution.
In the multicenter CLI-OPCI trial [68] , OCT identified adverse features requiring further intervention in 35% of cases. The OCT arm had a significantly lower risk of death and MI at 1 year.
Several single-center OCT trials suggest the potential to improve post-PCI decision-making [69] [70] [71] . The ILUMIEN series has provided multicenter evidence of a potential role. In ILUMIEN I, OCT was shown to impact stent selection substantially: both the length (68%) and diameter (39%) of the selected stent were modified, resulting in reduction of malapposition (from 51% to 19%) and resultant edge dissection (from 16% to 5%). In ILUMIEN II, the incidence of malapposition, tissue protrusion and stent edge dissection were significantly less when OCTguided versus IVUS. In ILUMIEN III, OCT-guided stenting resulted in stent expansion that was comparable to IVUS-guidance and improved compared to angiography-guidance. OCT was also associated with less malapposition and untreated edge dissection; clinical outcomes were similar among the three groups at 30 days.
A Bayesian network meta-analysis [72] of 17,882 patients compared clinical outcomes following IVUS or OCT versus coronary angiography alone for stent implantation. Image-guided PCI was associated with significant reduction of MACE.
| Recommendations
The expert consensus for appropriate use is summarized in Table 7 . 
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